JP2010536821A5 - - Google Patents

Download PDF

Info

Publication number
JP2010536821A5
JP2010536821A5 JP2010521405A JP2010521405A JP2010536821A5 JP 2010536821 A5 JP2010536821 A5 JP 2010536821A5 JP 2010521405 A JP2010521405 A JP 2010521405A JP 2010521405 A JP2010521405 A JP 2010521405A JP 2010536821 A5 JP2010536821 A5 JP 2010536821A5
Authority
JP
Japan
Prior art keywords
methyl
piperazin
benzamide
tert
butyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010521405A
Other languages
English (en)
Japanese (ja)
Other versions
JP5444547B2 (ja
JP2010536821A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/060788 external-priority patent/WO2009024550A1/en
Publication of JP2010536821A publication Critical patent/JP2010536821A/ja
Publication of JP2010536821A5 publication Critical patent/JP2010536821A5/ja
Application granted granted Critical
Publication of JP5444547B2 publication Critical patent/JP5444547B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010521405A 2007-08-20 2008-08-18 Lxr調節因子としてのn−ベンジル,n’−アリールカルボニルピペラジン誘導体 Expired - Fee Related JP5444547B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07114602.1 2007-08-20
EP07114602 2007-08-20
PCT/EP2008/060788 WO2009024550A1 (en) 2007-08-20 2008-08-18 N-benzyl, n' -arylcarbonylpiperazine derivatives as lxr modulators

Publications (3)

Publication Number Publication Date
JP2010536821A JP2010536821A (ja) 2010-12-02
JP2010536821A5 true JP2010536821A5 (OSRAM) 2013-12-05
JP5444547B2 JP5444547B2 (ja) 2014-03-19

Family

ID=40032504

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010521405A Expired - Fee Related JP5444547B2 (ja) 2007-08-20 2008-08-18 Lxr調節因子としてのn−ベンジル,n’−アリールカルボニルピペラジン誘導体

Country Status (12)

Country Link
EP (1) EP2190827B1 (OSRAM)
JP (1) JP5444547B2 (OSRAM)
CN (1) CN101848899B (OSRAM)
AR (1) AR067975A1 (OSRAM)
AT (1) ATE495161T1 (OSRAM)
CA (1) CA2694604C (OSRAM)
CL (1) CL2008002429A1 (OSRAM)
DE (1) DE602008004562D1 (OSRAM)
MX (1) MX2010001847A (OSRAM)
PE (1) PE20091241A1 (OSRAM)
TW (1) TW200922582A (OSRAM)
WO (1) WO2009024550A1 (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8314091B2 (en) 2007-08-20 2012-11-20 Msd Oss B.V. N-benzyl,N'-arylcarbonylpiperazine derivatives
TW201022230A (en) * 2008-08-28 2010-06-16 Organon Nv 1-(4-ureidobenzoyl)piperazine derivatives
BRPI1016232A2 (pt) * 2009-04-29 2023-04-11 Kowa Co Composto de carbinol, medicamento, regulador de lxr, composição farmacêutica, método para prevenir e/ou tratar doenças, e, uso do composto de carbinol
US8242260B2 (en) 2009-08-28 2012-08-14 Novartis Ag Compounds and compositions as protein kinase inhibitors
US20130274212A1 (en) 2010-09-07 2013-10-17 Snu R&Db Foundation Sesterterpene Compounds and Use Thereof
EP3626309B1 (en) 2012-08-13 2023-03-08 The Rockefeller University Lxrbeta agonist for the treatment of cancer
CN103159687A (zh) * 2013-04-12 2013-06-19 苏州科捷生物医药有限公司 一种2-胺基吡嗪-5甲酸的合成方法
CA3010883A1 (en) 2016-01-11 2017-07-20 The Rockefeller University Methods for the treatment of myeloid derived suppressor cells related disorders
AU2018373028A1 (en) 2017-11-21 2020-04-30 Inspirna, Inc. Polymorphs and uses thereof
WO2021119397A1 (en) 2019-12-13 2021-06-17 Rgenix, Inc. Metal salts and uses thereof
WO2023240376A1 (zh) * 2022-06-12 2023-12-21 中国医学科学院药物研究所 肠道上皮细胞核受体抑制子NCoR作为靶标在筛选药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0742208A1 (en) * 1995-05-05 1996-11-13 Grelan Pharmaceutical Co., Ltd. 2-Ureido-benzamide derivatives
BR0209932A (pt) * 2001-05-22 2004-10-13 Neurogen Corp Composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, preparação farmacêutica embalada, métodos para modular ligação de mch a um receptor de mch e de mvc, para alterar a atividade de transdução de sinal de um receptor de mch em uma célula, para tratar uma doença ou distúrbio associado com a ativação de receptor de mch patogênico obesidade e para determinar a presença ou ausência de receptor de mch em uma amostra, e, uso de um composto
SE0102764D0 (sv) * 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
FR2892722B1 (fr) * 2005-11-02 2008-08-15 Clinigenetics Sa Composes de type methanone et leur utilisation dans des compositions pharmaceutiques notamment pour le traitement des maladies cardiovasculaires
WO2007092065A2 (en) * 2005-11-14 2007-08-16 Irm Llc Compounds and compositions as lxr modulators
CN101378807A (zh) * 2005-12-21 2009-03-04 先灵公司 H3拮抗剂/反相激动剂与食欲抑制剂的组合

Similar Documents

Publication Publication Date Title
JP2010536821A5 (OSRAM)
RU2388750C2 (ru) Ингибиторы фосфодиэстеразы 4, включая аналоги n-замещенного диариламина
RU2424240C2 (ru) Антибактериальные производные пиперидина
JP2007519754A5 (OSRAM)
RU2009126624A (ru) Производные 2-(пиперидин-4-ил)-4-фенокси-или фенилаинопиримидина в качестве ненуклеозидных ингибитров обратной транскриптазы
RU2000128036A (ru) Амидиновые соединения
JP2017523972A5 (OSRAM)
RU2009121775A (ru) Пиридильное неароматическое азот-содержащее гетероцикло-1-карбоксилатное производное
NZ590268A (en) 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
RU2006135111A (ru) Производные тиазола
JP2018522823A5 (OSRAM)
JP2013510122A5 (OSRAM)
JP2018502877A5 (OSRAM)
JP2010538076A5 (OSRAM)
JP2011503103A5 (OSRAM)
JP2005517006A5 (OSRAM)
RU2005132616A (ru) Производные 2-фенокси и 2-фенилсульфонамида с ссr3 антагонистической активностью для лечения астмы и других воспалительных или иммунологических заболеваний
JP2015501799A5 (OSRAM)
JP2014502988A5 (OSRAM)
RU2018145761A (ru) Сульфонамидное соединение или его соль
RU2010138577A (ru) ИНГИБИТОРЫ РЕЦЕПТОРА ХЕМОКИНА CxCR3
AR062299A1 (es) Derivados de bencimidazol
JP2015522607A5 (OSRAM)
JP2018048143A5 (OSRAM)
NZ612544A (en) Heterocyclic compounds suitable for the treatment of dyslipidemia